Abselion raises 6.6 million to transform protein quantification
BGF - 05-Dec-2024Investors back Amperia for faster, more accessible protein measurement
Join the club for FREE to access the whole archive and other member benefits.
Company Inventing and Investing in AI, Science and Biotech.
R42 actively invents and finances deep science ventures. We will work with you from the pre-seed inventing stage through to growth stage. We are excited to work with passionate teams who are working to develop revolutionary technology to address pressing needs of our time. Our expertise in science, strategic planning, financing and a global network enables founders to grow and cultivate their ideas into reality.
Visit website: https://www.r42group.com/
Details last updated 09-Apr-2020
Investors back Amperia for faster, more accessible protein measurement
The UK-based company prepares for clinical trials with its innovative NF1 drug, HLX-1502
Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests
Trials on mitochondrial transfusion might help tackle many ageing diseases
Funding targets early-stage companies and postdoc researchers with unique ideas